Trials / Conditions / Leukemia, Acute Lymphoblastic

Leukemia, Acute Lymphoblastic

20 registered clinical trials studyying Leukemia, Acute Lymphoblastic — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias NCT06364423	National Cancer Institute (NCI)	Phase 1 / Phase 2
Recruiting	CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma NCT06101381	University of Sao Paulo	Phase 1 / Phase 2
Active Not Recruiting	Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients NCT05306301	Gruppo Italiano Malattie EMatologiche dell'Adulto	Phase 2
Completed	Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy NCT05064787	Pack Health	N/A
Recruiting	Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention NCT06626893	Azienda Ospedaliero-Universitaria di Parma	N/A
Completed	CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicit NCT05440409	National Cancer Institute (NCI)	—
Completed	Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation NCT04942730	St. Petersburg State Pavlov Medical University	Phase 2
Recruiting	A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia NCT04307576	Mats Heyman	Phase 3
Recruiting	Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leuk NCT04209244	Rigshospitalet, Denmark	N/A
Recruiting	A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia NCT03911128	Mats Heyman	—
Completed	Safety of Expanded Haploidentical Natural Killer Cells for Leukemia NCT04327037	Belarusian Research Center for Pediatric Oncology, Hematology and Immunology	Phase 1
Terminated	CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL NCT02935543	University of Pennsylvania	Phase 2
Terminated	Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses NCT02580981	New Mexico Cancer Research Alliance	N/A
Completed	GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia NCT02799147	St. Petersburg State Pavlov Medical University	Phase 1 / Phase 2
Completed	Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse NCT02393859	Amgen	Phase 3
Terminated	iCare for Cancer Patients NCT02435550	University of Florida	N/A
Terminated	Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT NCT02349178	Medical College of Wisconsin	Phase 2
Unknown	Vincristine PK and PD in the AYA Population Compared to Younger Children NCT02360930	Children's Hospital Los Angeles	—
Terminated	Acute Lymphoblastic Leukemia Registry at Asan Medical Center NCT01761682	Asan Medical Center	—
No Longer Available	Erwinase Master Treatment Protocol NCT00590915	Phoenix Children's Hospital	—